跳转至内容
Merck
CN

J3774

Monoclonal Anti-JAK1 antibody produced in mouse

2 mg/mL, clone JAK1-193, purified immunoglobulin, buffered aqueous solution

别名:

Anti-Janus Kinase 1

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352203
MDL number:
Conjugate:
unconjugated
Clone:
JAK1-193, monoclonal
Application:
ARR, ELISA (i), WB
Citations:
4
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

mouse

conjugate

unconjugated

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

JAK1-193, monoclonal

form

buffered aqueous solution

mol wt

antigen 130 kDa

species reactivity

rat, human, mouse

concentration

2 mg/mL

technique(s)

indirect ELISA: suitable, microarray: suitable, western blot: 2-4 μg/mL using extract from Raji cells

UniProt accession no.

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... JAK1(3716)
mouse ... Jak1(16451)
rat ... Jak1(84598)

General description

The Janus kinases (JAKs) are protein tyrosine kinases that modulate cytokine signaling during immunological responses and hematopoiesis. JAK family members consist of four isoforms, namely, JAK1, JAK2, JAK3 and TYK2. JAK1 plays a crucial role in mediating the JAK/STAT signaling response to interleukin 6. Alterations in JAK functions have been implicated in heart and immunological disorders, as well as in hematopoietic malignancies . Monoclonal Anti-JAK1 antibody is specific for human JAK1 (approx. 130 kDa).

Immunogen

The peptide sequence is identical in mouse and rat JAK1.
synthetic peptide corresponding to amino acids 543-555 of human JAK1, conjugated to KLH

Application

Monoclonal Anti-JAK1 antibody is suitable for use in western blot (2-4 μg/mL using extract from Raji cells), indirect ELISA and microarray.

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium aside.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

未找到合适的产品?  

试试我们的产品选型工具.

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Neal K Williams et al.
Journal of molecular biology, 387(1), 219-232 (2009-04-14)
The Janus kinases (JAKs) are a pivotal family of protein tyrosine kinases (PTKs) that play prominent roles in numerous cytokine signaling pathways, with aberrant JAK activity associated with a variety of hematopoietic malignancies, cardiovascular diseases and immune-related disorders. Whereas the
William Vainchenker et al.
Seminars in cell & developmental biology, 19(4), 385-393 (2008-08-07)
The four mammalian Janus kinase (JAK) family members, JAK1, JAK2, JAK3 and TYK2, are non-receptor protein tyrosine kinases (PTKs) that are crucial for cytokine receptor signaling in blood formation and immune responses. Mutations and translocations in the JAK genes leading
D Guschin et al.
The EMBO journal, 14(7), 1421-1429 (1995-04-03)
The protein tyrosine kinases JAK1, JAK2 and Tyk2 and STATs (signal transducers and activators of transcription) 1 and 3 are activated in response to interleukin-6 (IL-6) in human fibrosarcoma cells. In mutant cells lacking JAK1, JAK2 or Tyk2, the absence
Hui Shang et al.
Journal of biochemical and molecular toxicology, 35(10), e22882-e22882 (2021-09-25)
Human cervical cancer is the fourth most common carcinoma in women in the world. The JAK/STAT3 signaling pathways crucially regulate cell growth and apoptosis. It is a significant target signaling pathway for the development of novel antitumor medicine. This study

相关内容

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持